Zhejiang Int'l Group Co

Zhejiang Int'l Group Co Operating Expenses

The Total Operating Expenses of Zhejiang Int'l Group Co (000411.SZ) as of Nov 1, 2026 is 633.86 M CNY. In the previous year, Total Operating Expenses was 399.82 M CNY — a change of 58.54% (higher).

Operating Expenses

633.86 MCNY

YoY

58.54%

Last updated:

Total Operating Expenses of Zhejiang Int'l Group Co is 2025 633.86 M CNY. Total Operating Expenses of Zhejiang Int'l Group Co was 2024 399.82 M CNY. It decreases by 58.54% higher compared to the previous year.

The Zhejiang Int'l Group Co Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2018
292.16 M CNY
Jan 1, 2019
344.74 M CNY
Jan 1, 2020
359.01 M CNY
Jan 1, 2021
401.28 M CNY
Jan 1, 2022
440.03 M CNY
Jan 1, 2023
418.53 M CNY
Jan 1, 2024
399.82 M CNY
Jan 1, 2025
633.86 M CNY
The Zhejiang Int'l Group Co Operating Expenses history
YEAROperating ExpensesYoY
633.86 MCNY+58.54%
399.82 MCNY-4.47%
418.53 MCNY-4.89%
440.03 MCNY+9.66%
401.28 MCNY+11.77%
359.01 MCNY+4.14%
344.74 MCNY+18.00%
292.16 MCNY-1.46%
296.48 MCNY+14.10%
259.84 MCNY+9.52%
237.26 MCNY+4.32%
227.42 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zhejiang Int'l Group Co Stock analysis

What does Zhejiang Int'l Group Co do? Zhejiang Int'l Group Co., Ltd. generates revenue by wholesaling and retailing pharmaceuticals and medical devices. The company buys products from pharmaceutical manufacturers or suppliers and distributes them to distributors, medical institutions, and pharmacies. It also sells directly to consumers through retail terminals. The firm operates exclusively within Mainland China, serving a broad customer base across the healthcare sector. The business model relies on purchasing products from manufacturers or suppliers, then reselling them through wholesale channels to medical institutions and pharmacies, or via retail terminals to end consumers. This dual-channel approach allows the company to reach both institutional and individual customers without direct manufacturing involvement. Mainland China represents the sole market for all its operations. Zhejiang Int'l Group Co., Ltd. focuses on pharmaceutical and medical device distribution, targeting distributors, medical institutions, and pharmacies as key wholesale clients. Retail sales are directed toward consumers through its own retail terminals. The company does not engage in manufacturing, instead acting as a middleman between producers and end users within the Chinese healthcare market. Zhejiang Int'l Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zhejiang Int'l Group Co stock

Total Operating Expenses of Zhejiang Int'l Group Co is 633.86 M CNY in 2025.

Total Operating Expenses of Zhejiang Int'l Group Co changed from 399.82 M CNY to 633.86 M CNY, representing a 58.54% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Zhejiang Int'l Group Co since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Zhejiang Int'l Group Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Zhejiang Int'l Group Co

All Key Metrics — Zhejiang Int'l Group Co